18650-38-9 Usage
Description
(R)-Piperidine-2-carboxylic acid methyl ester hydrochloride is a chiral compound that exists in two enantiomeric forms, with the (R)-configuration being the desired one for specific applications. It is a white to off-white powder and is used in the synthesis of various organic compounds, particularly those with potential therapeutic properties.
Uses
Used in Pharmaceutical Industry:
(R)-Piperidine-2-carboxylic acid methyl ester hydrochloride is used as a key intermediate in the synthesis of aromatic compounds with immunoregulatory functions. Its unique (R)-configuration allows for the development of targeted therapies that can modulate the immune system, potentially leading to treatments for various immune-related disorders and diseases.
Used in Chemical Synthesis:
As a versatile building block, (R)-Piperidine-2-carboxylic acid methyl ester hydrochloride is used in the preparation of a wide range of organic compounds, including pharmaceuticals, agrochemicals, and other specialty chemicals. Its reactivity and functional groups enable the formation of diverse molecular structures, making it a valuable asset in the field of organic chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 18650-38-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,8,6,5 and 0 respectively; the second part has 2 digits, 3 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 18650-38:
(7*1)+(6*8)+(5*6)+(4*5)+(3*0)+(2*3)+(1*8)=119
119 % 10 = 9
So 18650-38-9 is a valid CAS Registry Number.
InChI:InChI=1/C16H36N.C7H6O2/c1-5-9-13-17(14-10-6-2,15-11-7-3)16-12-8-4;8-7(9)6-4-2-1-3-5-6/h5-16H2,1-4H3;1-5H,(H,8,9)/q+1;/p-1
18650-38-9Relevant articles and documents
DIHYDROPYRIDAZINE-3,5-DIONE DERIVATIVE AND PHARMACEUTICALS CONTAINING THE SAME
-
Paragraph 1328, (2016/01/30)
The present invention provides a dihydropyridazine-3,5-dione derivative or a salt thereof, or a solvate of the compound or the salt, a pharmaceutical drug, a pharmaceutical composition, a sodium-dependent phosphate transporter inhibitor, and a preventive and/or therapeutic agent for hyperphosphatemia, secondary hyperparathyroidism, chronic renal failure, chronic kidney disease, and arteriosclerosis associated with vascular calcification comprising the compound as an active ingredient, and a method for prevention and/or treatment.
Discovery of molecular switches within the ADX-47273 mGlu5 PAM scaffold that modulate modes of pharmacology to afford potent mGlu5 NAMs, PAMs and partial antagonists
Lamb, Jeffrey P.,Engers, Darren W.,Niswender, Colleen M.,Rodriguez, Alice L.,Venable, Daryl F.,Conn, Jeffrey P.,Lindsley, Craig W.
scheme or table, p. 2711 - 2714 (2011/06/20)
This Letter describes a chemical lead optimization campaign directed at a weak mGlu5 NAM discovered while developing SAR for the mGlu 5 PAM, ADX-47273. An iterative parallel synthesis effort discovered multiple, subtle molecular switches that afford potent mGlu5 NAMs, mGlu5 PAMs as well as mGlu5 partial antagonists.
Synthesis and reactions of α-(trifluromethanesulfonyloxy) enecarbamates prepared from N-acyllactams
Foti,Comins
, p. 2656 - 2657 (2007/10/02)
-
